Peer Review reports
From: CDC50A might be a novel biomarker of epithelial ovarian cancer-initiating cells
| Original Submission | ||
|---|---|---|
| 6 Apr 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| 19 Jun 2022 | Reviewed | Reviewer Report |
| 22 Jun 2022 | Reviewed | Reviewer Report |
| 6 Jul 2022 | Author responded | Author comments - Lingya Pan |
| Resubmission - Version 5 | ||
| 6 Jul 2022 | Submitted | Manuscript version 5 |
| 13 Jul 2022 | Author responded | Author comments - Lingya Pan |
| Resubmission - Version 6 | ||
| 13 Jul 2022 | Submitted | Manuscript version 6 |
| 17 Jul 2022 | Author responded | Author comments - Lingya Pan |
| Resubmission - Version 7 | ||
| 17 Jul 2022 | Submitted | Manuscript version 7 |
| 25 Jul 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 8 | ||
| Submitted | Manuscript version 8 | |
| Publishing | ||
| 28 Jul 2022 | Editorially accepted | |
| 19 Aug 2022 | Article published | 10.1186/s12885-022-09953-y |
You can find further information about peer review here.